We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Zero Cardiac Calcium Reduces Heart Attack Risk

By HospiMedica International staff writers
Posted on 23 Aug 2017
Patients with a coronary artery calcium (CAC) score of zero have significantly lower risk of future heart attack or stroke, claims a new study.

Researchers at the University of Texas (UT) Southwestern Medical Centre (Dallas, TX, USA), Baptist Health South Florida (Miami, FL, USA), and other institutions examined the computerized tomography (CT) scans of the chest and heart of 6,184 patients (45-84 years of age) participating in the multi-ethnic study of atherosclerosis (MESA) study, with no prior history of heart attack or stroke. More...
All participants underwent two CAC scans to establish CAC score; 3,415 participants had a CAC score of O and 508 had a score of 0-10.

The results showed that during median follow-up of 10.3 years, there were 123 cardiovascular disease (CVD) events. Patients with a CAC score of 1-10 experienced higher CVD event rates (5.5/1,000 person years), compared to 2.9/1,000 person years in those with a CAC score of 0. Age, current smoking, and hypertension significantly predicted CVD, but non HDL-cholesterol significantly predicted CVD only in those with a CAC score of 1-10. The study was published on August 7, 2017, in JACC: Cardiovascular Imaging.

“Our findings suggest that individuals with no calcium buildup in their blood vessels may not have to take statins, despite the presence of other risk factors that cause coronary disease,” concluded lead author cardiologist Parag Joshi, MD, of UT Southwestern. “New findings suggest that adding a CT scan for calcium may be worthwhile as doctors and patients discuss treatment options. A CT scan is a test that is easily done, costs about 100 bucks in most major cities, and can give a lot more information about the patient's 10-year risk.”

CAC is a noninvasive marker of plaque load in coronary arteries indicative of atherosclerotic plaque, but bears no relationship to plaque stability or instability. It is usually determined by conducting an electron beam computerized tomography scan (EBCT). Advantages of CAC scoring include variability on repeated testing and consistent thresholds of risk. Disadvantages include radiation exposure and lack of further information regarding a patient's functional capacity, which could be inferred from an exercise tolerance test.

Related Links:
University of Texas (UT) Southwestern Medical Centre
Baptist Health South Florida

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.